| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |